Market Tracker

01/26 3:08am ET

Theravance Inc (NASDAQ:THRX)

11.78
Data as of Jan 23
 -0.21 / -1.75%
Today’s Change
11.16
Today|||52-Week Range
32.88
-16.75%
Year-to-Date

Today’s Trading

Previous close11.99
Today’s open11.98
Day’s range11.43 - 12.13
Volume1,011,022
Average volume (3 months)981,255
Market cap$1.4B
Dividend yield8.49%
Data as of 4:00pm ET, 01/23/2015

Growth & Valuation

Earnings growth (last year)-735.00%
Earnings growth (this year)+31.24%
Earnings growth (next 5 years)-167.64%
Revenue growth (last year)-96.50%
P/E ratioNM
Price/Sales767.43
Price/Book4.39

Competitors

 Today’s
change
Today’s
% change
ANACAnacor Pharmaceutica...+0.82+2.46%
TSROTESARO Inc+0.40+0.99%
GWPHGW Pharmaceuticals P...+0.51+0.68%
CMRXChimerix Inc-0.63-1.62%
Data as of 4:00pm ET, 01/23/2015

Financials

Next reporting dateFebruary 5, 2015
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$4.8M
Annual profit (last year)-$170.7M
Net profit margin-3,587.66%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Senior Vice President-
Operations
Frank C. Pasqualone
Corporate headquarters
South San Francisco, California

Forecasts